Was Concurrent Antibiotic Use during Immunotherapy Associated with Higher Mortality for Patients with Advanced Hepatocellular Carcinoma?
Sign Up to like & getrecommendations! Published in 2022 at "Liver Cancer"
DOI: 10.1159/000526944
Abstract: aCancer Center, Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, China; bBengbu Medical College, Bengbu, China; cThe Key Laboratory of… read more here.
Keywords: concurrent antibiotic; people hospital; use immunotherapy; immunotherapy associated ... See more keywords
Immunotherapy-associated autoimmune hemolytic anemia
Sign Up to like & getrecommendations! Published in 2017 at "Journal for Immunotherapy of Cancer"
DOI: 10.1186/s40425-017-0214-9
Abstract: BackgroundImmunotherapy has been widely used in the treatment of several solid and hematologic malignancies. Checkpoint inhibitors have been the forefront of cancer immunotherapy in recent years. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death… read more here.
Keywords: anemia; autoimmune hemolytic; immunotherapy; immunotherapy associated ... See more keywords
Immunotherapy Associated Neurotoxicity in Pediatric Oncology
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.836452
Abstract: Novel immunotherapies are increasingly being employed in pediatric oncology, both in the upfront and relapsed/refractory settings. Through various mechanisms of action, engagement and activation of the immune system can cause both generalized and disease site-specific… read more here.
Keywords: oncology; immunotherapy associated; pediatric oncology; associated neurotoxicity ... See more keywords
Interstitial granulomatous dermatitis and concurrent immunotherapy associated encephalitis with nivolumab and ipilimumab.
Sign Up to like & getrecommendations! Published in 2022 at "Dermatology online journal"
DOI: 10.5070/d328257399
Abstract: Immune-related adverse events (irAEs) are common in patients receiving immune checkpoint inhibitors for metastatic melanoma and other advanced malignancies. Cutaneous, gastrointestinal, and endocrine (thyroid) irAEs are most prevalent, whereas neurologic irAEs are rare. We present… read more here.
Keywords: associated encephalitis; immunotherapy associated; granulomatous dermatitis; interstitial granulomatous ... See more keywords